270 related articles for article (PubMed ID: 16730419)
1. Association of TNFSF11 gene promoter polymorphisms with bone mineral density in postmenopausal women.
Mencej S; Prezelj J; Kocijancic A; Ostanek B; Marc J
Maturitas; 2006 Oct; 55(3):219-26. PubMed ID: 16730419
[TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis.
Mencej S; Albagha OM; Prezelj J; Kocjan T; Marc J
J Mol Endocrinol; 2008 Jun; 40(6):273-9. PubMed ID: 18502820
[TBL] [Abstract][Full Text] [Related]
3. The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density.
Mencej-Bedrac S; Prezelj J; Kocjan T; Teskac K; Ostanek B; Smelcer M; Marc J
J Mol Endocrinol; 2009 Mar; 42(3):239-47. PubMed ID: 19131500
[TBL] [Abstract][Full Text] [Related]
4. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
[TBL] [Abstract][Full Text] [Related]
5. Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women.
Arko B; Prezelj J; Kocijancic A; Komel R; Marc J
Maturitas; 2005 Jul; 51(3):270-9. PubMed ID: 15978970
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women.
Choi JY; Shin A; Park SK; Chung HW; Cho SI; Shin CS; Kim H; Lee KM; Lee KH; Kang C; Cho DY; Kang D
Calcif Tissue Int; 2005 Sep; 77(3):152-9. PubMed ID: 16151677
[TBL] [Abstract][Full Text] [Related]
7. -643C > T RANKL gene polymorphism is associated with osteoporosis in Tunisian postmenopausal women.
Sassi R; Sahli H; Cheour E; Sellami S; El Gaaied ABA
Climacteric; 2017 Aug; 20(4):374-378. PubMed ID: 28453307
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of eNOS gene polymorphisms in relation to BMD in postmenopausal women.
Firat SC; Cetin Z; Samanci N; Aydin F; Balci N; Gungor F; Firat MZ; Luleci G; Karauzum SB
Maturitas; 2009 Aug; 63(4):352-6. PubMed ID: 19520527
[TBL] [Abstract][Full Text] [Related]
9. Raloxifene pharmacodynamics is influenced by genetic variants in the RANKL/RANK/OPG system and in the Wnt signaling pathway.
Mencej-Bedrač S; Zupan J; Mlakar SJ; Zavratnik A; Preželj J; Marc J
Drug Metabol Drug Interact; 2014; 29(2):111-4. PubMed ID: 24615483
[TBL] [Abstract][Full Text] [Related]
10. TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta.
Vidal C; Brincat M; Xuereb Anastasi A
Maturitas; 2006 Mar; 53(4):386-95. PubMed ID: 16343827
[TBL] [Abstract][Full Text] [Related]
11. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
[TBL] [Abstract][Full Text] [Related]
12. Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men.
Yamada Y; Ando F; Niino N; Shimokata H
Mol Genet Metab; 2003 Nov; 80(3):344-9. PubMed ID: 14680982
[TBL] [Abstract][Full Text] [Related]
13. TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women.
Mencej-Bedrač S; Preželj J; Marc J
Maturitas; 2011 Jul; 69(3):263-7. PubMed ID: 21411255
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the tumor necrosis factor superfamily member 11 gene polymorphism with bone mineral density and bone fracture frequency in patients with postmenopausal osteoporosis.
Wawrzyniak A; Skrzypczak-Zielinska M; Krela-Kazmierczak I; Michalak M; Marszalek D; Marcinkowska M; Zakerska-Banaszak O; Slomski R
Adv Med Sci; 2020 Sep; 65(2):291-297. PubMed ID: 32446200
[TBL] [Abstract][Full Text] [Related]
15. Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese Women. The Japanese Population-based Osteoporosis (JPOS) Study.
Morita A; Iki M; Dohi Y; Ikeda Y; Kagamimori S; Kagawa Y; Matsuzaki T; Yoneshima H; Marumo F;
Int J Epidemiol; 2004 Oct; 33(5):979-88. PubMed ID: 15358739
[TBL] [Abstract][Full Text] [Related]
16. Bone mass effects of a BMP4 gene polymorphism in postmenopausal women.
Ramesh Babu L; Wilson SG; Dick IM; Islam FM; Devine A; Prince RL
Bone; 2005 Mar; 36(3):555-61. PubMed ID: 15777683
[TBL] [Abstract][Full Text] [Related]
17. Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density.
García-Unzueta MT; Riancho JA; Zarrabeitia MT; Sañudo C; Berja A; Valero C; Pesquera C; Paule B; González-Macías J; Amado JA
Horm Metab Res; 2008 Mar; 40(3):219-24. PubMed ID: 18348083
[TBL] [Abstract][Full Text] [Related]
18. Association of the G-174C variant in the interleukin-6 promoter region with bone loss and fracture risk in older women.
Moffett SP; Zmuda JM; Cauley JA; Stone KL; Nevitt MC; Ensrud KE; Hillier TA; Hochberg MC; Joslyn G; Morin P; Cummings SR;
J Bone Miner Res; 2004 Oct; 19(10):1612-8. PubMed ID: 15355555
[TBL] [Abstract][Full Text] [Related]
19. Association of a single nucleotide variant in the human tumour necrosis factor alpha promoter region with decreased bone mineral density.
Ota N; Nakajima T; Ezura Y; Iwasaki H; Suzuki T; Hosoi T; Orimo H; Inoue S; Ito H; Emi M
Ann Hum Biol; 2002; 29(5):550-8. PubMed ID: 12396374
[TBL] [Abstract][Full Text] [Related]
20. Gene-gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women.
Zupan J; Mencej-Bedrac S; Jurković-Mlakar S; Prezelj J; Marc J
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):102-6. PubMed ID: 19896533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
